Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Accumulated Expenses (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Accumulated Expenses for 3 consecutive years, with $24.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 183.6% year-over-year to $24.9 million, compared with a TTM value of $24.9 million through Dec 2025, up 183.6%, and an annual FY2025 reading of $24.9 million, up 183.6% over the prior year.
  • Accumulated Expenses was $24.9 million for Q4 2025 at BrightSpring Health Services, up from $1.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $26.7 million in Q2 2025 and bottomed at $1.4 million in Q3 2025.
  • Average Accumulated Expenses over 3 years is $11.4 million, with a median of $6.1 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses skyrocketed 180.93% in 2024, then soared 183.6% in 2025.
  • Year by year, Accumulated Expenses stood at $3.1 million in 2023, then skyrocketed by 180.93% to $8.8 million in 2024, then skyrocketed by 183.6% to $24.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for BTSG at $24.9 million in Q4 2025, $1.4 million in Q3 2025, and $26.7 million in Q2 2025.